The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Ark Therapeutics plc

20 Feb 2013 12:54

ABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics plc

ABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics plc

PR Newswire

London, February 20

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A

PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Identity of the person whose positions/ Aberforth Partners LLP, ondealings are being disclosed:

behalf of discretionary clients.(b) Owner or controller of interests and shortpositions disclosed, if different from 1(a):The naming of nominee or vehicle companies isinsufficient

(c) Name of offeror/offeree in relation to Ark Therapeutics Group plcwhose relevant securities this form relates:

Use a separate form for each offeror/offeree(d) If an exempt fund manager connected withan offeror/offeree, state this and specifyidentity of offeror/offeree:(e) Date position held/dealing undertaken: 19 February 2013(f) Has the discloser previously disclosed, or Y/N NOare they today disclosing, under the Code in

respect of any other party to this offer? If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror orofferee to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares Interests Short positions Number % Number %(1) Relevant securities owned 20,580,092 9.83 0 0.0and/or controlled:(2) Derivatives (other thanoptions):(3) Options and agreements topurchase/sell:TOTAL: 20,580,092 9.83 0 0.0

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchaseor sell relevant securities, should be given on a Supplemental Form 8 (OpenPositions).

(b) Rights to subscribe for new securities (including directors' and otherexecutive options)

Class of relevant security in N/Arelation to which subscription rightexists:Details, including nature of the N/Arights concerned and relevantpercentages:

If there are positions or rights to subscribe to disclose in more than oneclass of relevant securities of the offeror or offeree named in 1(c), copytable 2(a) or (b) (as appropriate) for each additional class of relevantsecurity.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit security securities Ordinary Shares Sale 4,000,000 0.7812p

(b) Derivatives transactions (other than options)

Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position N/A

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Optionrelevant description purchasing, securities price

date moneysecurity e.g. call selling, to which per unit e.g. paid/ option varying option American, received etc. relates European per unit etc. N/A(ii) Exercising Class of relevant Product Number of Exercise price per security description securities unit e.g. call optionN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit

security (if applicable) e.g. subscription, conversion N/A

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities ofthe offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (asappropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement orunderstanding, formal or informal, relating to relevant securities which maybe an inducement to deal or refrain from dealing entered into by the personmaking the disclosure and any party to the offer or any person acting inconcert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options orderivatives

Details of any agreement, arrangement or understanding, formal or informal,between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevantsecurities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None(c) AttachmentsIs a Supplemental Form 8 (Open Positions) attached? Y/N NODate of disclosure: 20 February 2013Contact name: David Holland, for Aberforth Partners LLPTelephone number: 0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a RegulatoryInformation Service and must also be emailed to the Takeover Panel atmonitoring@disclosure.org.uk . The Panel's Market Surveillance Unit isavailable for consultation in relation to the Code's dealing disclosurerequirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Date   Source Headline
24th Sep 20205:21 pmRNSResult of General Meeting
23rd Sep 20203:15 pmRNSDirector/PDMR Shareholding
17th Sep 20203:21 pmRNSDirector/PDMR Shareholding
17th Sep 202010:59 amRNSHolding(s) in Company
17th Sep 202010:57 amRNSDirector/PDMR Shareholding
16th Sep 20203:14 pmRNSDirector/PDMR Shareholding
2nd Sep 20207:00 amRNSDelisting, Posting of Circular and Notice of AGM
17th Aug 20207:00 amRNSHolding(s) in Company
13th Aug 20207:00 amRNSAcquisition and Delisting
26th Jun 20207:00 amRNSInterim Results
22nd Jun 20207:00 amRNSBlock listing Interim Review
4th May 20207:00 amRNSBusiness Update and Financing
14th Apr 202012:07 pmRNSSecond Price Monitoring Extn
14th Apr 202012:02 pmRNSPrice Monitoring Extension
25th Mar 20207:00 amRNSAGM Update
31st Jan 20204:52 pmRNSFinal Results
29th Jan 20207:00 amRNSConfirmation of Funding
23rd Dec 20191:01 pmRNSTrading Update
20th Dec 20197:00 amRNSBlock listing six monthly return
5th Jul 20197:00 amRNSNEW CONTRACT WITH MEDIVET GROUP
28th Jun 20197:00 amRNSInterim results for 6 months ended 31 March 2019
25th Jun 20197:00 amRNSAppointment of Broker and Interim results update
20th Jun 201912:05 pmRNSBLOCK LISTING SIX MONTHLY RETURN
23rd Apr 20193:37 pmRNSDirector/PDMR Shareholding
23rd Apr 20193:35 pmRNSIssue of Warrants
23rd Apr 20193:35 pmRNSDirector/PDMR Shareholding
23rd Apr 201910:58 amRNSDirector/PDMR Shareholding
8th Apr 20195:50 pmRNSHolding(s) in Company
27th Mar 20192:46 pmRNSResult of AGM
27th Mar 20197:00 amRNSAGM Update
27th Feb 201910:40 amRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSNotice of AGM
11th Feb 20192:59 pmRNSHolding(s) in Company
8th Feb 20197:00 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSPRELIMINARY ANNOUNCEMENT
29th Jan 20197:00 amRNSConfirmation of Funding
18th Jan 20197:00 amRNSNotice of Results
9th Jan 20194:07 pmRNSTrading Update
20th Dec 201810:48 amRNSBlock listing Interim Review
24th Oct 20187:00 amRNSTrading Update
13th Sep 20187:00 amRNSAppointment of Chief Financial Officer
6th Sep 201812:21 pmRNSHolding(s) in Company
29th Aug 20187:00 amRNSNeil Wood MBE joins Board of PVG plc
22nd Aug 20187:00 amRNSDirectorate Change
15th Aug 20187:00 amRNSMajor contract signed in the US
3rd Aug 20182:58 pmRNSHolding(s) in Company
25th Jun 20185:44 pmRNSNotification of Major Holdings
20th Jun 20184:33 pmRNSBlock listing Interim Review
15th Jun 20187:00 amRNSInterim Results
27th Mar 20184:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.